Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer A Byrne

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Nature|December 30, 2025
Put pressure on publishers to follow best practice - external regulation is the answerJennifer A Byrne
Biomarker Insights|April 22, 2020
<i>Biomarker Insights</i> Editor-in-Chief AnnouncementJennifer A Byrne
Research Integrity and Peer Review|February 17, 2018
Improving the peer review of narrative literature reviewsJennifer A Byrne
Anesthesia and Analgesia|November 25, 2025
The Problem of Wrongly Identified and Nonverifiable Nucleotide Sequences and Cell Lines in Research Papers, or How to Study Things That May Not ExistJennifer A Byrne
Experimental Cell Research|August 23, 2005
D53 (TPD52L1) is a cell cycle-regulated protein maximally expressed at the G2-M transition in breast cancer cellsRose Boutros, Jennifer A Byrne
FEBS Letters|February 19, 2020
Digital magic, or the dark arts of the 21<sup>st</sup> century-how can journals and peer reviewers detect manuscripts and publications from paper mills?Jennifer A Byrne, Jana Christopher
Plos Biology|May 9, 2025
More science friction for less science fictionJennifer A Byrne, Stefan Stender
Clinical Biochemistry|December 29, 2015
Quality and reporting practices in an Australian cancer biobank cohortAmanda Rush, Jennifer A Byrne
Accountability in Research|November 12, 2024
The research literature is an unsafe workplaceJennifer A Byrne, Adrian G Barnett
Adipocyte|September 13, 2016
Dropping in on the lipid droplet- tumor protein D52 (TPD52) as a new regulator and resident proteinYuyan Chen, Sarah Frost, Jennifer A Byrne
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Nature|December 30, 2025
Put pressure on publishers to follow best practice - external regulation is the answerJennifer A Byrne
Biomarker Insights|April 22, 2020
<i>Biomarker Insights</i> Editor-in-Chief AnnouncementJennifer A Byrne
Research Integrity and Peer Review|February 17, 2018
Improving the peer review of narrative literature reviewsJennifer A Byrne
Anesthesia and Analgesia|November 25, 2025
The Problem of Wrongly Identified and Nonverifiable Nucleotide Sequences and Cell Lines in Research Papers, or How to Study Things That May Not ExistJennifer A Byrne
Experimental Cell Research|August 23, 2005
D53 (TPD52L1) is a cell cycle-regulated protein maximally expressed at the G2-M transition in breast cancer cellsRose Boutros, Jennifer A Byrne
FEBS Letters|February 19, 2020
Digital magic, or the dark arts of the 21<sup>st</sup> century-how can journals and peer reviewers detect manuscripts and publications from paper mills?Jennifer A Byrne, Jana Christopher
Plos Biology|May 9, 2025
More science friction for less science fictionJennifer A Byrne, Stefan Stender
Clinical Biochemistry|December 29, 2015
Quality and reporting practices in an Australian cancer biobank cohortAmanda Rush, Jennifer A Byrne
Accountability in Research|November 12, 2024
The research literature is an unsafe workplaceJennifer A Byrne, Adrian G Barnett
Adipocyte|September 13, 2016
Dropping in on the lipid droplet- tumor protein D52 (TPD52) as a new regulator and resident proteinYuyan Chen, Sarah Frost, Jennifer A Byrne
Pageof 10